Pediatric Director Phase I Experimental Therapeutics

About this Opportunity 

The Phase I / Experimental Therapeutics Program Director in the Children’s Mercy Cancer Center (CMCC) will lead a multi-disciplinary team of professionals focusing on early phase clinical trials and new drug discovery in childhood cancer.  The Director will oversee and set the vision for clinical, research, and education development while pursuing and securing funding to support these efforts.  The Director will: maintain and expand the national Phase I consortia membership for the CMCC; mentor and support faculty and trainee participation; and  work with hospital leaders to align the vision and direction the Phase I program with that of the Section, Division, and Hospital. 

The Phase I / Experimental Therapeutics Program in the Children’s Mercy Cancer Center has been enrolling patients since 2010.  Clinical trials available in the program have been a mixture of academic consortias including expanded COG Phase 1+ trials, direct Pharma-sponsored trials, and local investigator initiated trials.  CMCC’s Phase I program is closely partnered with the hospital’s Pediatric Clinical Pharmacology program, one of the largest in the country.  The program has had 3 Hematology/Oncology faculty closely involved in the program’s trial and patient oversight and this is anticipated to grow.  The Phase I program is well supported with a dedicated Advanced Nurse Practitioner and 4 clinical research coordinators.  In addition to the Clinical Pharmacology core laboratories, the Phase I program has direct access as a full NCI-designated Cancer Center consortium member with the University of Kansas Cancer Center’s Phase I program and its nationally recognized drug discovery program located just a few miles away in Kansas City, KS, and as well the KU School of Pharmacy on the nearby Lawrence, KS campus.  CMH faculty are embedded in numerous labs within the KU Cancer Center.  Faculty appointments will include membership within the KU Cancer Center.

Requirements

•          Pediatric Hematology/Oncology board certified MD, MD/PhD, or equivalent degree
•          Associate or Full Professor rank or eligibility required
•          Experience in Phase I trials required with one or more of the following preferred

o    serving as local PI for Phase I trials,

o    experience as Study Chair of a Phase I or I/II trial

o    track record of academic productivity in Phase I trials

•          Preference given for individual with one or more of the following

o    Clinical Pharmacology training, PhD or Pharm D degree in addition to MD or DO degree, and/or

o    Experience in pre-clinical drug discovery research

o    Grant supported research

o    Participation in national Phase I consortia

o    Phase I leadership roles in other institutions or pharma industry

COG membership, particularly if participant in Phase I or II COG trial committees either sponsored by the Phase I committee or by a Disease committee

Salary and academic range are commensurate with experience.  
Qualified candidate should submit their CV to physicianjobs@cmh.edu

EEO Employer / Disabled / Vet

Children’s Mercy Kansas City is an independent, non-profit, 390-bed pediatric health system, providing over half a million patient encounters each year for children from across the country. Children’s Mercy is ranked by U.S. News & World Report in nine specialties. We have received Magnet® recognition five times for excellence in nursing services. In affiliation with the University of Missouri-Kansas City and the university of Kansas School of Medicine, our faculty of more than 800 pediatric specialists and researchers is actively involved in clinical care, pediatric research and educating the next generation of pediatricians and pediatric subspecialists. 

The Children’s Mercy Research Institute (CMRI) integrates research and clinical care with nationally recognized expertise in genomic medicine, precision therapeutics, population health and health care innovation. In 2021 the CMRI moved into a nine story, 375,000 square foot space emphasizing a translational approach to research in which clinicians and researchers work together to accelerate the pace of discovery that enhances care. We invite you to visit Children’s Mercy Hospital virtually at https://www.youtube.com/watch?v=GtlXT3xK-bI

Kansas City is a thriving cultural and economic city with more than 2 million residents. Our city’s long list of attractions includes world class museums, a vibrant arts scene, professional sports, superb shopping, great jazz clubs, and the best places to enjoy barbeque! The city offers low cost-of-living, excellent commute times, and a vibrant downtown, eight-block dining, entertainment and shopping district.  Kansas City offers excellent opportunities for both public and private school venues and is home to several colleges and universities. It’s a community with a heart – friendly, easy-going and forward-thinking – a great place to live and pursue a career. For more information about activities in Kansas City go to www.visitkc.com

 For more information about Children’s Mercy Kansas City and about Kansas City itself, visit childrensmercy.org/careers/take-your-place/

EEO Employer/Disabled/Vet